Niox Group PLC 9.1% potential upside indicated by Peel Hunt Limited

Niox Group PLC with ticker (LON:NIOX) now has a potential upside of 9.1% according to Peel Hunt Limited.



Peel Hunt Limited set a target price of 77 GBX for the company, which when compared to the Niox Group PLC share price of 71 GBX at opening today (29/09/2023) indicates a potential upside of 9.1%. Trading has ranged between 34 (52 week low) and 75 (52 week high) with an average of 370,951 shares exchanging hands daily. The market capitalisation at the time of writing is £280,855,300.

NIOX Group plc is a United Kingdom-based diagnostics and management company that is focused on asthma. The Company’s product NIOX uses patented technology to measure fractional exhaled nitric oxide (FeNO). Its NIOX FeNO measurement and monitoring products are used by physicians around the globe to help improve asthma diagnosis and management. The Company offers NIOX VERO, a point of care device for the accurate measurement of nitric oxide (NO) as a biomarker of airway inflammation to help diagnose and manage asthma. The device is used by healthcare professionals to improve asthma care, which assists diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance, and reducing the likelihood of exacerbations in at-risk patients compared to traditional monitoring. The Company offers products and services in around 50 countries.